SCN8A ENCEPHALOPATHY

Clinical trials for SCN8A ENCEPHALOPATHY explained in plain language.

Never miss a new study

Get alerted when new SCN8A ENCEPHALOPATHY trials appear

Sign up with your email to follow new studies for SCN8A ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for kids with devastating seizure disorders

Disease control Ongoing

This study is testing an investigational drug called PRAX-562 to see if it is safe and can help reduce seizures in children with rare, severe forms of epilepsy caused by specific genetic changes (SCN2A or SCN8A). Children in the study will first receive either the drug or a place…

Matched conditions: SCN8A ENCEPHALOPATHY

Phase: PHASE2, PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

SCN8A ENCEPHALOPATHY

Get alerted when new SCN8A ENCEPHALOPATHY trials appear

New hope for kids with devastating seizure disorders